Sonova stock holds steady after fiscal 2025 growth
Published on 08/09/2026 at 14:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sonova (CH0012549785) finished fiscal 2025 with revenue of CHF 3.87 billion and EBIT of CHF 776.6 million, giving investors a fresh reference point for the hearing-care group before the next earnings cycle. The company also reported net income of CHF 547.2 million for the year, which shows how the earnings base held up through the cycle.
CHF 3.87 billion revenue
Sonova stock is best read through the 2025 report numbers: revenue reached CHF 3.87 billion, EBIT came to CHF 776.6 million, and net income was CHF 547.2 million. Those figures matter because they frame the company’s current scale and profitability before the market gets a new catalyst.
For investors, the comparison point is clear: fiscal 2025 revenue of CHF 3.87 billion and EBIT of CHF 776.6 million are the latest hard metrics available in the company profile, and they set the baseline for any new quarter or guidance update. The operating result also implies an EBIT margin of about 20.1%, based on the reported revenue and EBIT.
Profitability still matters
Net income of CHF 547.2 million in fiscal 2025 gives another anchor for valuation work, especially when paired with EBIT of CHF 776.6 million. The earnings mix remains important for a stock that investors usually judge on both top-line growth and margin discipline.
The next measurable step will be the first new report after fiscal 2025, because the market will compare any new sales or profit trend with these year-end figures. That makes the 2025 report a useful base case rather than a historical footnote.
Sonova fiscal 2025 at a glance
Revenue, EBIT, and net income are the three numbers that frame the current Sonova story and the next reporting comparison.
Hearing aids remain central
The product side of the business is still dominated by hearing solutions, which is why any new sales update will be judged against the fiscal 2025 base. Sonova’s reported revenue of CHF 3.87 billion and EBIT of CHF 776.6 million show that the core franchise is still large enough to move the group result.
In practical terms, the company’s next product or segment update will matter most if it changes the relationship between growth and margin. That is the lens investors will use when new data arrives.
Market value pending
Sonova stock can be tracked against the fiscal 2025 base of revenue at CHF 3.87 billion, EBIT at CHF 776.6 million, and net income at CHF 547.2 million until a fresh market quote is verified. Those numbers provide a factual anchor for valuation discussions even before the next trading reference is added.
The company remains listed in Switzerland, and the next report will determine whether the current earnings base is extended or revised.
Sonova company data
- Company: Sonova Holding AG
- ISIN: CH0012549785
- Ticker: SIX: SOON
- Trading venue: SIX Swiss Exchange
- Sector / Industry: Health Care / Health Care Equipment
- Index membership: SMI
